LYZAPAM NOCTAMID LORTEM

Dose: 0.5 to 1.5 mg
Single Dose: 1 (1)
Frequency: 24 hourly
Route: PO
Instructions: Once at bed time

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Benzodiazepine. It belongs to Chloride Channel Potentiater (GABA operated) pharmacological group on the basis of mechanism of action and also classified in Sedatives and Hypnotics pharmacological group.The Molecular Weight of Lormetazepam is 335.20.

Lormetazepam is contraindicated in conditions like Myasthenia gravis,Respiratory depression,Acute pulmonary insufficiency,Sleep apnea syndrome.

The symptomatic adverse reactions produced by Lormetazepam are more or less tolerable and if they become severe, they can be treated symptomatically, these include Sleepiness, Headache, Ataxia.

Lormetazepam is primarily indicated in conditions like Insomnia, Nausea, vertigo, labyrinthine disorders.

No data regarding the interactions of Lormetazepam was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store . Protect from Sunlight.

Lormetazepam should be used with caution in patients with respiratory disease, muscle weakness, history of drug or alcohol abuse, marked personality disorder; avoid regular use during pregnancy (risk of neonatal withdrawl symptoms); use only if clear indication such as seizure control (high doses during late pregnancy or labour may cause neonatal hypothermia, hypotonia and respiratory depression); breast-feeding (present in milk, avoid if possible); reduce dose in elderly and debilitated, and in hepatic (avoid if severe) and renal impairment (start with small doses if severe); avoid prolong use (abrupt withdrawl thereafter); porphyria. It should not be used alone to treat depression (or anxiety associated with depression) or psychosis